Medication info
Ultrafin Semi Tablets

Ultrafin Semi Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›18.75mg / 1 tablet
Manufacturer / importer
SPC Co., Ltd.
Appearance
Light yellow oblong film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201503182 · Approved 2015.05.27 · Insurance code 669700200

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Older adults Administer the usual adult dose. However, since the elimination half-life of tramadol increases by 17% when tramadol is administered orally to older adults aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal failure For patients with moderate renal failure (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal failure (creatinine clearance below 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, this drug does not need to be readministered after dialysis to maintain its analgesic effect. Patients with hepatic failure Carefully consider extending the dosing interval in patients with moderate hepatic failure. Do not administer this drug to patients with severe hepatic failure.
Child dose
Children 12 years of age and older: An initial dose of 4 tablets is recommended; thereafter, doses should be taken at intervals of at least 6 hours, not exceeding 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term use is required because of the nature and severity of the condition, perform regular monitoring to determine whether treatment with this drug should be continued.

Ingredients

Manufacturer
SPC Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate pain
  • severe pain
  • acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute or chronic pain ranging from moderate to severe.

How to take

Adult dose

Older adults Administer the usual adult dose. However, since the elimination half-life of tramadol increases by 17% when tramadol is administered orally to older adults aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal failure For patients with moderate renal failure (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal failure (creatinine clearance below 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, this drug does not need to be readministered after dialysis to maintain its analgesic effect. Patients with hepatic failure Carefully consider extending the dosing interval in patients with moderate hepatic failure. Do not administer this drug to patients with severe hepatic failure.

Child dose

Children 12 years of age and older: An initial dose of 4 tablets is recommended; thereafter, doses should be taken at intervals of at least 6 hours, not exceeding 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term use is required because of the nature and severity of the condition, perform regular monitoring to determine whether treatment with this drug should be continued.

Precautions

This medication may place a burden on the liver, so those who regularly consume more than three glasses of alcohol daily should consult a doctor or pharmacist before taking it. This medication can rarely cause severe skin allergic reactions, so if skin rash or hypersensitivity symptoms occur, stop taking it immediately and seek medical attention. One of the active ingredients, tramadol, may increase the risk of seizures, and the risk may be heightened if taken with certain antidepressants or opioid analgesics, so caution is required. In patients with serious respiratory diseases, this medication may pose a risk of respiratory depression, so it should be administered in places equipped with cardiopulmonary resuscitation equipment. Taking this medication with alcohol or central nervous system depressants may lead to severe drowsiness, respiratory depression, or even coma, so co-administration should be avoided unless directed by a healthcare professional. Patients with head injuries or brain diseases should use this medication cautiously, as it may exacerbate symptoms of increased intracranial pressure or respiratory depression. This medication may lead to psychological and physical dependence, so long-term use requires careful observation of potential dependence and abuse risks. Patients with diminished liver function or liver disease should consult with a doctor before taking this medication, and dosage adjustments may be necessary. The metabolism of this medication may vary based on the activity of the enzyme CYP2D6, with some individuals metabolizing it quickly, thereby heightening the risk of respiratory depression and other side effects, necessitating caution. This medication should not be administered to children under 12 years of age or teenagers under 18 years of age following certain surgeries, and even for those 12 years and older with respiratory issues or risk factors, administration should be avoided. This medication may worsen symptoms of sleep apnea or hypoxemia, so patients with these symptoms should periodically monitor their condition while taking it. Symptoms of hyponatremia, or decreased sodium concentration in the blood, may occur, especially in elderly patients or those with relevant risk factors, thus monitoring for symptoms is necessary. In case of overdose, severe respiratory depression, seizures, or liver damage may occur; therefore, adherence to recommended dosage is essential, and if dosage is unclear or overdose is suspected, immediate emergency treatment should be sought. Women who are pregnant or breastfeeding should consult a doctor before taking this medication, particularly nursing mothers, as it may be transmitted through breast milk and pose risks to the infant, making avoidance preferable. This medication may cause drowsiness or dizziness, so caution is advised when driving or operating machinery, and these symptoms may be aggravated if taken with alcohol or other central nervous system depressants. During treatment with this medication, care should be taken to avoid overlapping use with other analgesics or medications containing acetaminophen, and possible drug interactions should be discussed with a doctor or pharmacist regarding other medications being taken. This medication should be kept out of reach of children and managed carefully to prevent misuse and accidental ingestion.

Side effects

Liver damage, acute generalized eruption of pustules, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, fatal respiratory suppression, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, hives, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremors, paresthesia, attention deficit, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, constricted pupils, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, weakness, chest pain, emotional disturbance, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, warmth sensation, weight loss, increased serum creatinine, anaphylactic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, influence on emotional instability, delirium, suicidal thoughts, muscle hypertonicity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, thrombocytopenia, anemia, decreased hemoglobin, decreased erythrocytes, leukopenia, leukocytosis, congestive heart failure, vertigo, confusion, exacerbation of migraine, involuntary muscle contractions, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function tests, oliguria, rash, increased sweating, hives, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, loss of appetite, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased erythrocytes, leukopenia, leukocytosis, thrombocytopenia, palpitations, hypertension, arrhythmias, tachycardia, worsening hypertension, aortic coarctation, gastrointestinal bleeding, increased cholesterol, weight loss, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nosebleeds, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, indigestion, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, withdrawal symptoms, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, hives, rash, bronchospasm, toxic skin necrosis, allergic reactions, convulsions, serotonin syndrome, serotonin syndrome, respiratory arrest, cardiac arrest, QT prolongation, abdominal discomfort, lethargy, pallor, hyperhidrosis, adrenal insufficiency, hyperalgesia, withdrawal symptoms, sweating, rigidity, pain, diarrhea, upper respiratory syndrome, sweating, agitation, hyperactivity, gastrointestinal symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture ingress. Additionally, it is recommended to store it at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Light yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.